Karmanos Cancer Institute — Detroit, Michigan

Public research footprint of Karmanos Cancer Institute, compiled from the ClinicalTrials.gov public registry.

1,678

Registered studies

434

Active

174

Recruiting now

943

Completed

252

Stopped or withdrawn

Most-studied conditions

Myelodysplastic Syndrome · Locally Advanced Malignant Solid Neoplasm · Metastatic Non-Cutaneous Melanoma · Recurrent Melanoma

Recently updated registry entries

NCT02196181 — Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer… (Active Not Recruiting)
NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Karmanos Cancer Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.